|

SMS-Based Remote Symptom Monitoring for Patients With Plasma Cell Disorders

RECRUITINGSponsored by Mayo Clinic
Actively Recruiting
SponsorMayo Clinic
Started2026-08-25
Est. completion2028-08-25
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site

Summary

This study evaluates whether daily SMS-based (text messages) symptom monitoring is feasible and acceptable in patients who are undergoing treatment for multiple myeloma (MM) or systemic light chain amyloidosis (AL), and whether it can help in early identification of symptoms that may require clinical attention.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age \>= 18 years
* Diagnosis of MM or AL based on IMWG diagnostic criteria
* Planned to start a new treatment within 14 days (+/-7 days)
* Able to provide written informed consent

Exclusion Criteria:

* Not able to give informed consent

Conditions3

AL AmyloidosisCancerMultiple Myeloma

Locations1 site

Mayo Clinic in Rochester
Rochester, Minnesota, 55905
Sarah Aug507-538-1301

Find trials near these locations

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.